29650534 |
Sequential ALK Inhibitors Can Select for Lorlatinib-Resistant Compound ALK Mutations in ALK-Positive Lung Cancer
Mino-Kenudson, M,
Friboulet, L,
Benes, CH,
Engelman, JA,
Yoda, S,
Gainor, JF,
Dardaei, L,
Iafrate, AJ,
Heist, RS,
Shaw, AT,
Dagogo-Jack, I,
Langenbucher, A,
Burke, BJ,
Hata, AN,
Ferris, LA,
Timonina, D,
Johnson, TW,
Hubbeling, H,
Timofeevski, S,
Lawrence, MS,
Kattermann, KE,
Lin, JJ,
Prutisto-Chang, K,
Riley, AK,
Lennerz, JK
|
Cancer Discov |
2018 |